Flamel Technologies S.A. (ADR) (FLML)

CAPS Rating:

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

View All Commentary (FLML)

Recs

4

Avatar Gtrinvestor (99.99) Submitted: 8/20/07 4:27 PM : Start Price: $12.53 FLML Score: -12.96

HG Rec that has been beaten up a lot... I mean a lot (the stock is trading about a 1/3 of its price at the beginning of the year).

As I put a bit of trust in the HG duo, I will go ahead and support their rec on this stock w/ an outperform myself here in CAPS. In real life I would probably buy a call option on this stock rather than invest in equity, b/c the downside is that you lose everything, and the upside is huge as well.

Report this Post Replies: 1 | Reply

Avatar Gtrinvestor (99.99) Submitted: 8/23/07 8:56 PM

Recs: 0 | Rec This

Holy cr*p, this one took a beating today. Apparently tests on their "once a day" version of their heart drug isn't doing too well, so the 2x a day version is still the one to count on. This doesn't sound too bad on the surface, except Teva (one of my top 10 stocks for personal investing) is going to make a generic version of the 2x a day version soon, so Flamel was counting on the 1x day version to be the new "branded" product (oops).
Therefore, in real life I would not invest in Flamable Flannel, but I'll keep my CAPS pick out here on the potential that my score goes positive on this stock through some divine act.

Report this Post Reply

Flamel Technologies S.A. (ADR) (FLML)

4

Featured Broker Partners